Viking Therapeutics, Inc. (VKTX)
After hours:
| Previous close | 52.10 |
| Open | 51.08 |
| Bid | 44.92 x 100 |
| Ask | 52.26 x 400 |
| Day's range | 48.20 - 52.85 |
| 52-week range | 8.28 - 99.41 |
| Volume | |
| Avg. volume | 3,496,042 |
| Market cap | 5.736B |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.92 |
| Earnings date | 24 July 2024 - 29 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 114.20 |
ZacksViking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $52.10, denoting a -0.69% change from the preceding trading day.
ZacksWall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Insider MonkeyHere’s Why Viking Therapeutics (VKTX) Shares Rose in Q1
Baron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter, the fund rose 15.33% (Institutional Shares), outperformed the Russell 3000 Growth Index, which gained 11.23%, and the S&P 500 Index, which advanced 10.56%. US equities continued […]
